What Immunome, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 11 |
| Sells | 7 | 28 |
| Total trades | 11 | 64 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 108,616 | 892,987 |
| Disposed | 232,168 | 1,446,739 |
| Net activity | −123,552 | −553,752 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Higgins Jack | Chief Scientific Officer | Sep 11 | Gift · G | −8,800 | — | — | 56,250 |
| Higgins Jack | Chief Scientific Officer | Sep 11 | Disclosed 10b5-1 sale · S | −13,200 | $25.32 | −$334K | 65,050 |
| Higgins Jack | Chief Scientific Officer | Sep 11 | Exercise / conversion · M | +18,000 | $1.35 | +$24.3K | 78,250 |
| Barchas Isaac | Director | Aug 12 | Open-market sale · S | −11,048 | $27.25 | −$301K | 92,211 |
| Barchas Isaac | Director | Aug 11 | Open-market sale · S | −62,291 | $26.23 | −$1.63M | 0 |
| Barchas Isaac | Director | Aug 10 | Open-market sale · S | −10,125 | $26.07 | −$264K | 62,291 |
| Barchas Isaac | Director | Aug 07 | Open-market sale · S | −15,248 | $26.06 | −$397K | 72,416 |
| Barchas Isaac | Director | Aug 06 | Open-market sale · S | −20,840 | $26.06 | −$543K | 87,664 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Aug 04 | Disclosed 10b5-1 sale · S | −90,616 | $25.09 | −$2.27M | 0 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Aug 04 | Exercise / conversion · M | +40,250 | $10.60 | +$427K | 90,616 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Aug 04 | Exercise / conversion · M | +50,366 | $12.92 | +$651K | 50,366 |
| Siegall Clay B | President and CEO | Jul 23 | Grant / award · A | +180,000 | — | — | 870,704 |
| Rosett Max | Chief Financial Officer | Jul 23 | Grant / award · A | +47,250 | — | — | 101,287 |
| Lechleider Robert | Chief Medical Officer | Jul 23 | Grant / award · A | +54,000 | — | — | 69,805 |
| Higgins Jack | Chief Scientific Officer | Jul 23 | Grant / award · A | +38,250 | — | — | 60,250 |
| Stoneman Sandra G. | CHIEF LEGAL OFFICER & GC | Jul 23 | Grant / award · A | +38,250 | — | — | 43,805 |
| Tsai Philip | Chief Technical Officer | Jul 23 | Grant / award · A | +38,250 | — | — | 81,550 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Jul 23 | Grant / award · A | +31,250 | — | — | 31,250 |
| Barchas Isaac | Director | Jul 07 | Open-market sale · S | −16,906 | $24.20 | −$409K | 108,504 |
| Horn Kinney | CHIEF BUSINESS OFFICER | Jul 07 | Disclosed 10b5-1 sale · S | −1,092 | $25.00 | −$27.3K | 0 |
Loading...
